coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Lytham St Annes PCN, Fylde · Health Inequalities Profile

    PCN U26788 · NHS Lancashire and South Cumbria Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    53,475

    Registered population

    51.8% aged 18–64

    34.0%

    Aged 65+

    ICB 20.0% · England 17.9%

    3.7%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    7.7%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~5,566

    Core20 residents (est.)

    Resident basis; registered basis ~4,360 · see page 3

    12,701

    Hypertension register

    +10.15% in 3 yrs · England +5.60%

    715

    SMI register

    73.8% of Fylde's

    1,491

    COPD register

    Reviews +3.31% in 3 yrs

    Forecast to 2030

    16,132

    Hypertension patients, 2030

    +3,431 on today

    61.9%

    QRISK ≥20% on statins, 2030

    +2.74pp over 3 yrs

    8.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    19.4 pp
    Core20 deprivation is concentrated in two practices.

    Practice Core20 shares span 19.4 pp: Parcliffe Medical Centre and Poplar House Surgery are at 19.4%, whereas Holland House Surgery and Fernbank Surgery are.

    1,368
    Lipid therapy and asthma reviews trail England.

    Asthma review coverage is 63.5% (England 65.7%; 1,368 unreviewed) and QRISK ≥ 20% lipid therapy is 56.0% (England 63.6%), which may reflect unverified recall.

    64.3%
    Diabetes and hypertension control exceed national benchmarks.

    Diabetes HbA1c control without frailty reaches 64.3% (England 57.4%, ICB 56.2%) and hypertension treatment to target is 71.3% (England 70.3%, Fylde 69.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 34.0% of the list, exceeding England's 17.9%

    Across the PCN, 53,475 patients are registered. Patients aged 65+ account for 34.0% (18,166 patients), above Fylde (29.0%), the ICB (20.0%) and England (17.9%), while 14.3% are aged 0–17 (Fylde 15.6%, ICB 19.6%, England 19.6%). In Census resident data, 96.3% identify as White (Fylde 96.3%, ICB 87.8%, England 81.1%) and 3.7% from ethnic minority backgrounds, including 1.4% Asian / Asian British (Fylde 1.4%, ICB 9.4%, England 9.6%). Ethnicity reflects Census usual residents rather than registered patients.

    Age profile

    0–1714.3%
    18–6451.8%
    65+34.0%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White96.3%
    Asian1.4%
    Mixed1.4%
    Other0.4%
    Black0.3%

    Older people · falls rows are Fylde local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Fylde LA)1,5312,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)64.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Fylde LA)7821,0219552024/25
    Falls deaths, all ages, per 100,000 (Fylde LA)15.418.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 7.7% overall but spans 19.4 percentage points between practices

    The PCN Core20 share is 7.7%, above Fylde (5.1%) but below the ICB (30.6%) and England (21.0%), with an estimated 5,566 resident Core20 population across IMD deciles 1 and 2. Practice shares span 19.4 percentage points: Parcliffe Medical Centre is at 19.4% (2,341 estimated patients) and Poplar House Surgery is at 19.4% (1,287 estimated patients), while Holland House Surgery and Fernbank Surgery record 0.0%. Reconciling practice registered totals (4,360) against resident estimates (5,566) will clarify outreach scale across the two concentrated practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Parcliffe19.4% · 2,341 patients
    Poplar House19.4% · 1,287 patients
    Ansdell5.7% · 732 patients
    Holland House0.0% · 0 patients
    Fernbank0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    715

    SMI register

    1.33% recorded prevalence

    294

    Learning disability register

    0.55% recorded prevalence

    36

    Care homes, 1,195 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    Fylde, Census 2021

    Recorded severe mental illness prevalence is 1.3% (715 patients; Fylde 1.3%, ICB 1.2%, England 1.0%), while learning disability prevalence is 0.6% (294 patients; Fylde 0.5%, ICB 0.6%, England 0.6%). The PCN catchment also encompasses 36 care homes with 1,195 beds. Care home bed capacity and recorded registers reflect catchment scale, though bed counts do not establish resident occupancy or registered patient use.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.3% (715 patients). Twelve-month blood pressure recording is 79.8% (England 83.4%), BMI recording is 77.2% (England 82.1%) and alcohol recording is 75.7% (England 81.8%), which may reflect recall gaps that audit would test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,701

    Hypertension register

    +10.15%

    Register growth, 3 yrs

    Fylde +9.01% · England +5.60%

    +1.41pp

    BP control, under 80

    ≤140/90 · +2.73pp aged 80+

    +3,431

    More patients by 2030

    Forecast 16,132 (28.65%)

    Hypertension case-finding and control

    Hypertension register prevalence is 23.6% (12,701 patients), above Fylde (21.9%), the ICB (17.2%) and England (15.2%), consistent with an older demographic (34.0% aged 65+ vs England 17.9%). Over 2023 to 2025, the register rose 10.2% (England +5.6%). Blood pressure control in patients aged under 80 reaches 67.5%, above Fylde (66.2%) and the ICB (67.1%) but trailing England (67.8%), with three-year progress (+1.4 pp) behind England (+2.1 pp). Observation periods for current counts were not supplied. Trailing national blood pressure control for under-80s indicates a priority to review recall and treatment titration.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy reaches 56.0%, trailing England (63.6%), the ICB (61.4%) and Fylde (56.5%). Lower uptake than England indicates a gap in primary prevention treatment.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026148,735£1.40£1.64£1.86£208,229
    Cardiovascular (all), 2025230,220£3.39£3.38£3.33£780,446

    In 2026, the PCN prescribed 148,735 items of lipid-regulating drugs at £1.40 per item, above Fylde (£1.26) but below the ICB (£1.64) and England (£1.86), spending £68,418 less than at England's unit cost across these items. Lower unit costs reflect item expenditure rather than prescribing efficiency or treatment appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +4.90%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.19%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.2% (3,746 patients; England 6.6%), but 12-month review coverage is 63.5%, trailing England (65.7%) and the ICB (65.0%), leaving an estimated 1,368 patients unreviewed. Asthma management items prescribed per 1000 5-19 Population are 2,000 rate (England 1,488 rate). COPD prevalence is 2.8% (1,491 patients; England 1.9%), with reviews at 78.1% (England 76.4%). Lower asthma review coverage could reflect recall shortfalls, which clinical audit would test.

    Cancer register and children's immunisation

    Cancer prevalence is 6.8% (3,669 patients; England 3.8%). In Q1 2025/26 childhood immunisations, 12-month 6-in-1 coverage is 98.9%, exceeding the 95.0% target. At age 5, MMR dose 2 and 4-in-1 booster coverage are both 91.9%, falling below the 95.0% target by 3.1 pp, while MMR dose 1 is 94.6% (a 2.7 pp difference). Slower booster uptake could reflect recall timing gaps, which scheduling audit would test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.9%

    England 91.0%

    6-in-1 complete primary course at 24 months94.7%

    England 92.2%

    MMR dose 1 at 24 months93.4%

    England 88.3%

    MMR dose 2 at age 591.9%

    England 82.8%

    4-in-1 pre-school booster at age 591.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of staged cancers in NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 known-stage cases), below England (55.3%) and 22.6 pp below the 75.0% national ambition for 2028. Staged share was 74.6% (8,863 of 11,883; England 67.0%). Early detection was lower in lung (31.1% vs England 33.8%) and bowel (44.2% vs England 47.0%), but higher in breast (86.0% vs England 85.4%). Reaching 75.0% requires about 2,010 additional early diagnoses across the ICB. Staged coverage and small site cohorts warrant caution; these system figures do not establish PCN performance. ICB early-stage shortfalls reinforce the need for robust primary care safety-netting.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional Jul 2026 data, Blackpool Teaching Hospitals NHS Foundation Trust achieved 98.0% on the 31-day cancer standard (standard 96.0%; ICB 93.6%, England 92.5%). However, the 62-day referral standard was 67.5% (standard 85.0%), trailing Lancashire Teaching Hospitals NHS Foundation Trust (75.0%), the ICB (73.6%) and England (71.2%). The 28-day faster diagnosis standard was 71.4% (standard 75.0%; Lancashire Teaching Hospitals 82.9%, England 79.3%). In diagnostics, 6+ week waits reached 21.8% for MRI and 16.5% for CT (England 9.9%). Provider data reflects acute capacity, not PCN delivery. Local acute diagnostic and 62-day delays may prolong time to confirmed cancer treatment.

    Pathways within standard (%)BlackpoolLancashireLiverpoolLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)71.3882.9075.4778.3979.32
    31-day treatment (96%)97.9689.4390.5193.6292.50
    62-day referral to treatment (85%)67.4875.0473.2673.6271.16
    Diagnostic waits over 6 weeks (%)BlackpoolLancashireLiverpoolEngland
    MRI21.802.416.4221.40
    CT16.4914.970.719.92
    Echocardiography7.5713.8512.5528.48
    Colonoscopy13.080.0033.1430.83
    Gastroscopy12.470.0044.9929.02
    All 15 DM01 tests26.5426.6511.5023.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In provisional Jun 2026 Community Services Dataset records, Fylde borough residents had 126,445 community service contacts, of which 72,000 (56.9%) were with adults aged 65+. These figures represent borough resident activity rather than provider or PCN caseloads. High community contact volumes among older adults indicate substantial local demand for integrated multidisciplinary and intermediate care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination and immunisation achievement varies across practices by 49.1 pp

    In 2025/26, England overall QOF achievement was 92.5%. Poplar House Surgery achieved 87.1% overall achievement, and Holland House Surgery achieved 97.3%. In the vaccination and immunisation domain, Poplar House Surgery achieved 33.4%, whereas Fernbank Surgery achieved 82.5% (England comparator 55.2%), with a practice range of 49.1 pp between Poplar House Surgery and Fernbank Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ansdell1115.745.6%65.8%75.5%
    Parcliffe11219.442.6%73.8%73.2%
    Fernbank Surgery1130.048.6%69.0%72.9%
    Holland House1140.042.3%57.2%70.8%
    Poplar House11819.442.8%58.6%63.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNFyldeAssetPCNFylde
    Care homes (catchment)36 (1,195 beds)n/aSchools (catchment)29n/a
    Children's centres35Places of worship3854
    Libraries34Primary schools (LA maintained)815
    Primary academies35Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    On the 3,746 asthma register, 12-month review coverage is 63.5%, below England (65.7%) and the ICB (65.0%), leaving an estimated 1,368 patients unreviewed. For discussion: the PCN could run structured recall using a single review template alongside inhaler prescribing checks and flexible appointment slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Two-list Core20 and lipid review

    QRISK ≥ 20% lipid therapy is 56.0% (England 63.6%, ICB 61.4%). Core20 share is 7.7% (England 21.0%) but spans 19.4 pp, reaching 19.4% at Parcliffe Medical Centre (2,341 estimated patients) and Poplar House Surgery (1,287). Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 3

    Learning disability register validation

    Learning disability QOF prevalence is 0.6% (294 patients; England 0.6%, Fylde 0.5%, list 53,475), with 2023 to 2025 growth (+3.5%) trailing England (+5.4%) and Fylde (+6.0%). For discussion: practices could validate diagnostic codes and cross-check lists with local authority social-care records where information-sharing agreements exist. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted deprivation outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Early presentation and referral audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Two-list Core20 and lipid review (p12)Core20 cohort (IMD quintile 1) · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 · 10YHP equity test · Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15